Peter MacCallum Cancer Centre at ESMO 2026

Oct 23–27, 2026 Madrid, Spain ~37k attendees Website

Peter MacCallum Cancer Centre takes part in 17 sessions at ESMO 2026 in Madrid. Its program centres on prostate cancer, from talazoparib with enzalutamide in DNA repair gene-mutated disease to radioligand therapy, and on long-term care in ALK-positive lung cancer. Other sessions cover circulating tumour DNA for residual disease in colorectal cancer and response-based strategies in metastatic kidney cancer.

OrganizationESMO 2026 Attendance
Peter MacCallum Cancer Centre
Melbourne, Australia
petermac.org
Cancer centre & hospital
Public cancer hospital and research centre in Melbourne, Australia, affiliated with the University of Melbourne.
Abstract
Fri Oct 23
14:02–14:07
Abstract
Fri Oct 23
14:29–14:34
Chair
Fri Oct 23
16:15–17:15
YO Vesalius Talk
with Aga Khan University Hospital
Talk
Fri Oct 23
16:55–17:15
Optimising radioligand therapy
Emerging therapeutic strategies in advanced prostate cancer
Genitourinary cancers
Abstract
Sat Oct 24
09:05–09:10
Chair
Sat Oct 24
10:15–11:00
Satellite
Sat Oct 24
13:33–14:03
Optimising outcomes for patients with ALK+ aNSCLC: A patient‑centred, practical care model for durable treatment benefit
Pfizer Oncology - The CROWN trial at 7 years: Transforming treatment of 1L ALK+ aNSCLC towards a chronic care model · with A Coruña University Hospital (CHUAC)
Lung & thoracic cancers
Satellite
Sat Oct 24
14:03–14:28
Shaping the future of long-term management in ALK+ aNSCLC: Implications of CROWN 7- year outcomes
Pfizer Oncology - The CROWN trial at 7 years: Transforming treatment of 1L ALK+ aNSCLC towards a chronic care model · with Prince of Wales Hospital, A Coruña University Hospital (CHUAC)
Lung & thoracic cancers
Chair
Sat Oct 24
16:30–18:00
Novel concepts for metastatic breast cancer: Looking to the future
with Latin American Cooperative Oncology Group
Breast cancerBiomarkers & precision oncology
Chair
Sun Oct 25
08:30–10:00
ctDNA in colorectal cancer: State-of-the-art and evolving clinical applications
with San Giovanni di Dio Hospital
Gastrointestinal cancers
Abstract
Sun Oct 25
08:40–08:45
Talk
Sun Oct 25
08:55–09:20
ctDNA for minimal residual disease: Overview of current evidence, recommendations and knowledge gaps
ctDNA in colorectal cancer: State-of-the-art and evolving clinical applications
Gastrointestinal cancers
Abstract
Sun Oct 25
10:42–10:47
Satellite
Sun Oct 25
13:25–13:40
Tailoring treatments for specific patient subgroups
Pierre Fabre Laboratories - BRAFV600E-mutant mCRC: Precision medicine in practice
Gastrointestinal cancersBiomarkers & precision oncology
Satellite
Sun Oct 25
13:55–14:25
From the clinic: Applying precision medicine in practice
Pierre Fabre Laboratories - BRAFV600E-mutant mCRC: Precision medicine in practice · with Vall d'Hebron University Hospital, MD Anderson Cancer Center, Charité – Universitätsmedizin Berlin
Gastrointestinal cancersBiomarkers & precision oncology
Talk
Sun Oct 25
14:45–15:05
Basis of the biology of radioligands for oncologists
Radioligand therapy: A game-changer in the treatment sequence of advanced neuroendocrine tumors
Sarcoma, CNS, head & neck and rare cancers
Abstract
Sun Oct 25
15:15–15:27
Invited Discussant LBA94, 4236O and 4237O
Proffered paper 1: Basic science and translational research
Chair
Mon Oct 26
08:30–10:00
How to optimise care for patients receiving prostate cancer systemic therapy
with Clemenceau Medical Center
Genitourinary cancers
Chair
Mon Oct 26
10:15–11:45
Rapid oral 2: Breast cancer, advanced stage
with Hospital Arnau de Vilanova, Memorial Sloan Kettering Cancer Center
Breast cancer
Chair
Mon Oct 26
10:15–11:30
Abstract
Mon Oct 26
10:35–10:50
Invited Discussant 4639RO, 4RO, 5RO and 4640RO
Rapid oral 2: Breast cancer, advanced stage
Breast cancer
Talk
Mon Oct 26
11:00–11:20
Timing and optimal local treatment for metastatic disease
Response-based adaptive strategies in primary metastatic kidney cancer
Genitourinary cancers
Talk
Mon Oct 26
13:05–13:15
From fellow to leader: Reflections on the long-term impact of an ESMO Fellowship
ESMO Fellowship Programme: Educational opportunities for young oncologists

Explore the full ESMO 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Madrid. Leave your work email and we’ll be in touch.

Privacy

Download the full ESMO 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from Peter MacCallum Cancer Centre

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by the European Society for Medical Oncology. Submit a correction